According to Medifast's latest financial reports the company's current earnings (TTM) are $0.12 B. a decrease over its 2022 earnings that were of $0.18 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.12 B | -31.61% |
2022 | $0.18 B | -14.56% |
2021 | $0.21 B | 61.25% |
2020 | $0.13 B | 47.36% |
2019 | $91.03 M | 31.82% |
2018 | $69.06 M | 74.26% |
2017 | $39.63 M | 47.56% |
2016 | $26.85 M | -6.36% |
2015 | $28.68 M | -16.28% |
2014 | $34.26 M | 2% |
2013 | $33.59 M | 44.4% |
2012 | $23.26 M | -16.75% |
2011 | $27.94 M | -12.14% |
2010 | $31.8 M | 63.85% |
2009 | $19.41 M | 136.71% |
2008 | $8.2 M | 35.74% |
2007 | $6.04 M | -142.56% |
2006 | -$14.2 M | -448.43% |
2005 | $4.07 M | 35.62% |
2004 | $3 M | -16.51% |
2003 | $3.59 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | -245.82% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | -$54.19 M | -142.87% | ๐บ๐ธ USA |
Bellerophon Therapeutics
BLPH | -$11.04 M | -108.73% | ๐บ๐ธ USA |